# Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/azienda-socio-sanitaria-territoriale-degli-spedali-civili-di-brescia/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 63.7 |
| Citations | 1,151,911 |
| City | Brescia |
| Country | IT |
| Description | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia is a research organisation in Brescia, IT. OpenAlex records 16,011 works and 1,151,911 citations for it. 3,480 researchers list it as their most recent affiliation. |
| Homepage | https://www.asst-spedalicivili.it |
| OpenAlex ID | https://openalex.org/I4210103289 |
| Researchers | 3,480 |
| ROR ID | https://ror.org/015rhss58 |
| Type | healthcare |
| Works | 16,011 |

## University papers

Showing 12 of 39.

- [Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients](https://scholariq.org/papers/antiphospholipid-syndrome-clinical-and-immunologic-manifestations-and-patterns/)
- [2019 update of the EULAR recommendations for the management of systemic lupus erythematosus](https://scholariq.org/papers/2019-update-of-the-eular-recommendations-for-the-management-of-systemic-lupus/)
- [2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS](https://scholariq.org/papers/2016-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in-4/)
- [EULAR recommendations for the management of antiphospholipid syndrome in adults](https://scholariq.org/papers/eular-recommendations-for-the-management-of-antiphospholipid-syndrome-in-adults/)
- [A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity](https://scholariq.org/papers/a-human-natural-killer-cell-subset-provides-an-innate-source-of-il-22-for/)
- [The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation](https://scholariq.org/papers/the-eular-points-to-consider-for-use-of-antirheumatic-drugs-before-pregnancy-and/)
- [EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome](https://scholariq.org/papers/eular-recommendations-for-women-s-health-and-the-management-of-family-planning/)
- [Towards tuberculosis elimination: an action framework for low-incidence countries](https://scholariq.org/papers/towards-tuberculosis-elimination-an-action-framework-for-low-incidence-countries/)
- [EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics](https://scholariq.org/papers/eular-recommendations-for-the-management-of-systemic-lupus-erythematosus-report/)
- [EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs](https://scholariq.org/papers/eular-recommendations-for-the-management-of-systemic-lupus-erythematosus-with/)
- [Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial](https://scholariq.org/papers/brentuximab-vedotin-with-chemotherapy-for-cd30-positive-peripheral-t-cell/)
- [Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice](https://scholariq.org/papers/vitamin-d-and-musculoskeletal-health-cardiovascular-disease-autoimmunity-and/)

## University researchers

- [Silvia Piantoni](https://scholariq.org/researchers/silvia-piantoni/)

## University top topics

Showing 8 of 25.

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Immunodeficiency and Autoimmune Disorders](https://scholariq.org/topics/immunodeficiency-and-autoimmune-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.